Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Biology » Biology - General » Advances in Medicine and Biology. Volume 50 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Brain, Body, Cognition - A continuation of Functional Neurology, Rehabilitation and Ergonomics
$325.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Facilitated Therapeutic Alliances Increase Treatment Retention among Injection Drug Users (pp. 143-156)
Tell A Friend
 
Tell someone you know about this product.
Facilitated Therapeutic Alliances Increase Treatment Retention among Injection Drug Users (pp. 143-156) $100.00
Authors:  (Karen F. Corsi, Nicole Speer, Sung-Joon Min, Mark Royer, Robert E. Booth, University of Colorado Denver-Anschutz Medical Campus, Department of Psychiatry, Division of Substance Dependence, Denver, Colorado, USA)
Abstract:
This study tested the effects of a facilitated therapeutic alliance (FTA) intervention between clients and addiction counselors on 1) treatment entry and retention, and 2) injection drug use and HIV risk behaviors. Six hundred and sixty-one street-recruited, out-of-treatment, opiate-injecting drug users were randomly assigned to a standard, strengths-based case management only (CM) intervention, or to receive CM plus FTA (CM/FTA). Participants were interviewed on their drug use and HIV risk behaviors at baseline, and at six months post-intervention. Chi-square tests found no effects of the intervention on treatment entry, but significant effects of the intervention on treatment retention. Twenty-eight percent of CM/FTA participants entered methadone maintenance treatment within 6 months of the intervention, compared with 30% of CM participants. However, among those who entered treatment, 78% of the CM/FTA participants remained in treatment more than 90 days, compared to 50% of CM participants. Treatment retention was associated with reductions in injection drug use, and unsafe injection behaviors. Given the effects of treatment retention on reduction of injection drug use and associated unsafe injection behaviors, these findings suggest a facilitated therapeutic alliance may be a critical component to treatment retention and associated reductions in HIV risk behaviors among opiate-injecting drug users. 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Facilitated Therapeutic Alliances Increase Treatment Retention among Injection Drug Users (pp. 143-156)